Xarelto is used to reduce the risk of stroke and blood clots in people with atrial fibrillation, not caused by a heart valve problem. There is limited information on how effective it is compared to warfarin (coumadin). The FDA approved it’s use in the US in November 2011.
A German magazine, Der Spiegel, published an article about the extraordinary amount of reported side effects in Germany from the drug Xarelto. They state:
- In 2013, for 8 months, 968 cases of (suspected) side effects, including 72 deaths.
- In 2012, for the full year, 750 cases of side-effects, including 58 cases of death.
Bayer projects $2b in sales for Xarelto. Via Reuters
– MedShadow Staff
